Willem S Lexmond1, Joana F Neves2, Samuel Nurko1, Torsten Olszak2, Mark A Exley2, Richard S Blumberg3, Edda Fiebiger4. 1. Division of Gastroenterology and Nutrition, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA. 2. Division of Gastroenterology, Hepatology, and Endoscopy, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA. 3. 1] Division of Gastroenterology, Hepatology, and Endoscopy, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA [2] These authors contributed equally to this work. 4. 1] Division of Gastroenterology and Nutrition, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA [2] These authors contributed equally to this work.
Abstract
OBJECTIVES: Recent experimental evidence suggests that environmental microbial factors early in life determine susceptibility to allergic diseases through inappropriate chemotaxis and local activation of CD1d-restricted, invariant chain natural killer T (iNKT) cells. In this study, we analyzed the involvement of these pathways in pediatric patients with eosinophilic esophagitis (EoE) before and after dietary allergen elimination. METHODS: mRNA expression levels of components of the C-X-C motif chemokine ligand 16 (CXCL16)-iNKT-CD1d axis were compared in esophageal biopsies from EoE patients vs. normal or inflammatory controls and before and after treatment. RESULTS: CXCL16, iNKT cell-associated cell marker Vα24, and CD1d were significantly upregulated in esophageal biopsies from EoE patients and correlated with the expression of inflammatory mediators associated with allergy. Upregulation of each of these factors was significantly more pronounced in patients aged <6 years at diagnosis, and this early-onset EoE subpopulation was characterized by a more prominent food allergic disease phenotype in a cohort-wide analysis. Successful, but not unsuccessful, treatment of early-onset EoE patients with dietary elimination of instigating allergens led to reduction in infiltrating iNKT cells and complete normalization of mRNA expression levels of CXCL16 and CD1d. CONCLUSIONS: Our observations place iNKT cells at the center of allergic inflammation associated with EoE, which could have profound implications for our understanding, treatment and prevention of this and other human allergic diseases.
OBJECTIVES: Recent experimental evidence suggests that environmental microbial factors early in life determine susceptibility to allergic diseases through inappropriate chemotaxis and local activation of CD1d-restricted, invariant chain natural killer T (iNKT) cells. In this study, we analyzed the involvement of these pathways in pediatric patients with eosinophilic esophagitis (EoE) before and after dietary allergen elimination. METHODS: mRNA expression levels of components of the C-X-C motif chemokine ligand 16 (CXCL16)-iNKT-CD1d axis were compared in esophageal biopsies from EoE patients vs. normal or inflammatory controls and before and after treatment. RESULTS:CXCL16, iNKT cell-associated cell marker Vα24, and CD1d were significantly upregulated in esophageal biopsies from EoE patients and correlated with the expression of inflammatory mediators associated with allergy. Upregulation of each of these factors was significantly more pronounced in patients aged <6 years at diagnosis, and this early-onset EoE subpopulation was characterized by a more prominent food allergic disease phenotype in a cohort-wide analysis. Successful, but not unsuccessful, treatment of early-onset EoE patients with dietary elimination of instigating allergens led to reduction in infiltrating iNKT cells and complete normalization of mRNA expression levels of CXCL16 and CD1d. CONCLUSIONS: Our observations place iNKT cells at the center of allergic inflammation associated with EoE, which could have profound implications for our understanding, treatment and prevention of this and other humanallergic diseases.
Authors: Samuel Koprak; Stephen Matheravidathu; Martin Springer; Sandra Gould; Francis J Dumont Journal: Cell Immunol Date: 2003-05 Impact factor: 4.868
Authors: C H Kim; E J Kunkel; J Boisvert; B Johnston; J J Campbell; M C Genovese; H B Greenberg; E C Butcher Journal: J Clin Invest Date: 2001-03 Impact factor: 14.808
Authors: S Jyonouchi; C L Smith; F Saretta; V Abraham; K R Ruymann; P Modayur-Chandramouleeswaran; M-L Wang; J M Spergel; A Cianferoni Journal: Clin Exp Allergy Date: 2014-01 Impact factor: 5.018
Authors: Dingding An; Sungwhan F Oh; Torsten Olszak; Joana F Neves; Fikri Y Avci; Deniz Erturk-Hasdemir; Xi Lu; Sebastian Zeissig; Richard S Blumberg; Dennis L Kasper Journal: Cell Date: 2014-01-16 Impact factor: 41.582
Authors: Ivan J Fuss; Frank Heller; Monica Boirivant; Francisco Leon; Masaru Yoshida; Stefan Fichtner-Feigl; Zhiqiong Yang; Mark Exley; Atsushi Kitani; Richard S Blumberg; Peter Mannon; Warren Strober Journal: J Clin Invest Date: 2004-05 Impact factor: 14.808
Authors: Mariette Lisbonne; Séverine Diem; Alexandre de Castro Keller; Jean Lefort; Luiza M Araujo; Patricia Hachem; Jean-Marie Fourneau; Stéphane Sidobre; Mitchell Kronenberg; Masuru Taniguchi; Peter Van Endert; Michel Dy; Philip Askenase; Momtchilo Russo; B Boris Vargaftig; André Herbelin; Maria C Leite-de-Moraes Journal: J Immunol Date: 2003-08-15 Impact factor: 5.422
Authors: Kelly M O'Shea; Seema S Aceves; Evan S Dellon; Sandeep K Gupta; Jonathan M Spergel; Glenn T Furuta; Marc E Rothenberg Journal: Gastroenterology Date: 2017-07-27 Impact factor: 22.682
Authors: Benjamin F Sallis; Lena Erkert; Sherezade Moñino-Romero; Utkucan Acar; Rina Wu; Liza Konnikova; Willem S Lexmond; Matthew J Hamilton; W Augustine Dunn; Zsolt Szepfalusi; Jon A Vanderhoof; Scott B Snapper; Jerrold R Turner; Jeffrey D Goldsmith; Lisa A Spencer; Samuel Nurko; Edda Fiebiger Journal: J Allergy Clin Immunol Date: 2017-12-19 Impact factor: 10.793